Altre lingue Optiscan Imaging Limited

Azioni

OIL

AU000000OIL4

Mercato chiuso - Australian S.E. Altri mercati azionari 07:46:48 03/05/2024			Variaz. 5gg	Var. 1 gen.
0,083 ^AUD	+2,47%		-2,35%	-1,19%

21/03	Optiscan Imaging riceve più di 670.000 dollari australiani come rimborso fiscale per la ricerca e sviluppo	MT
22/02	Optiscan Imaging Limited riporta i risultati degli utili per il semestre terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Optiscan Imaging Receives More Than AU$670,000 as R&D Tax Rebate	21/03
Optiscan Imaging Limited Reports Earnings Results for the Half Year Ended December 31, 2023	22/02
Optiscan Imaging Secures AU$3 Million Research Grant for Endomicroscope Device; Shares Rise 8%	13/02
Optiscan Imaging Appoints COO	23/10/23
Optiscan Imaging Limited Appoints Brendan Fafiani to the Role of Chief Operating Officer, Effective 6 November 2023	23/10/23
Cancer Images from Optiscan's Platform Comparable With Conventional Histology Analysis, Study Says	20/09/23
Optiscan Imaging Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Optiscan Imaging Completes Key Milestone for Telepathology Project	15/08/23
Optiscan Imaging Establishes New Commercial Operation in the US	03/04/23
Optiscan Imaging Confirms High Diagnostic Rate of Imaging Device	14/03/23
Optiscan Imaging Receives US FDA Feedback for Oral Imaging Product	02/03/23
Optiscan Imaging Limited Intends to Pursue De Novo Pathway for InVivage	02/03/23
Optiscan Imaging Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/02/23
Optiscan Imaging Limited Announces Partnership with Prolucid Technologies to Develop AI Algorithms	29/01/23
Optiscan Imaging Proposes Issuance of 6 Million Securities	25/10/22
Optiscan Imaging Acquiring Clinical Datasets from Managing Director; Shares Rise 4%	25/10/22
Optiscan Imaging Secures R&D Tax Rebate	24/10/22
Optiscan Imaging Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31/08/22
Optiscan Imaging Files US FDA Application for Oral Tissue Imaging Device	22/08/22
Optiscan Imaging : ASX Announcements – Optiscan Quarterly Activities Ended June 2022	22/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Optiscan Imaging Limited

Azioni

OIL

AU000000OIL4

Altre lingue

Filtri